Children with growth hormone deficiency are currently treated with daily injections of recombinant growth hormone. The burden of 365 injections per year and cold chain storage causes a poor medication adherence. Long-acting growth hormones were developed to decrease injection frequency and therefore to promote a better therapeutic compliance. This paper discusses what long-acting drugs are currently on the market and their mechanism of action, and identifies the patient groups that may benefit from them.
I LAGH (ormoni della crescita long-acting): cosa sono e a chi proporli?
Rodaro, Chiara;Tornese, Gianluca
2024-01-01
Abstract
Children with growth hormone deficiency are currently treated with daily injections of recombinant growth hormone. The burden of 365 injections per year and cold chain storage causes a poor medication adherence. Long-acting growth hormones were developed to decrease injection frequency and therefore to promote a better therapeutic compliance. This paper discusses what long-acting drugs are currently on the market and their mechanism of action, and identifies the patient groups that may benefit from them.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
MedicoeBambino_2406_371.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Digital Rights Management non definito
Dimensione
78.78 kB
Formato
Adobe PDF
|
78.78 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
